Influenza Virus Vaccine for the 2008-2009 Season
2008/2009 Season Lot Release Status (as of December 17, 2008)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers.
For information on flu vaccine distribution schedules, please contact the manufacturers directly.
|Manufacturer||Total Number of Lots Released by FDA|
Rue de l'Institut 89
B1330 Rixensart Belgium
ID Biomedical Corporation of Quebec
525 Cartier Blvd, West
Laval, Quebec 87V 3S8 Canada
297 North Bernardo Ave
Mountain View, CA 94043
Gaskill Road, Speke
Liverpool L24 9GR
Sanofi Pasteur Inc
Swiftwater, PA 18370
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Gaithersburg, Maryland, on February 21, 2008, to select the influenza virus strains for the composition of the influenza vaccine for use in the 2008-2009 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics, serological responses to 2007/2008 vaccines, and the availability of candidate strains and reagents.
The panel recommended that vaccines to be used in the 2008-2009 influenza season in the U.S. contain the following:
- an A/Brisbane/59/2007 (H1N1)-like virus;
- an A/Brisbane/10/2007 (H3N2)-like virus; *
- a B/Florida/4/2006-like virus. #
- * A/Brisbane/10/2007 is a current southern hemisphere vaccine virus.
#B/Florida/4/2006 and B/Brisbane/3/2007 (a B/Florida/4/2006-like virus) are current southern hemisphere vaccine viruses.
The influenza vaccine composition to be used in the 2008-2009 influenza season in the U.S. is identical to that recommended by the World Health Organization on February 14, 2008, for the Northern Hemisphere's 2008-2009 influenza season.